June 30, 2025
Source: drugdu
119
On June 26, 2025, the 23rd edition of CPhI China successfully concluded after three productive days at the Shanghai New International Expo Centre. Drugdu.com, a global B2B digital trading platform specializing in the pharmaceutical industry, showcased its comprehensive capabilities and platform value in facilitating international pharmaceutical trade, attracting visitors from around the world.
01|Nine Years of Growth: Earning Long-Term International Trust
Founded in 2016, Drugdu.com has built a solid track record over the past nine years. The platform now serves users across more than 220 countries and regions worldwide, covering sectors such as APIs, finished formulations, health products, pharmaceutical machinery, and medical devices.
Many long-standing customers visited the Drugdu booth during the exhibition to share their positive collaboration experiences and explore further international cooperation.
One long-term buyer from Latin America commented:
“We have found many Chinese suppliers on the Drugdu platform who are already certified by our local authorities. Every year, we discover new sourcing channels through Drugdu.”
02|Face-to-Face Engagement: Building Deeper Understanding and Trust
Compared to previous years, the Drugdu.com team made a special effort to provide on-site demonstrations and detailed guidance to help visitors better understand how the platform operates. Key highlights included:
How to optimize company profiles to attract international buyers;
How to improve inquiry conversion rates through better product descriptions and tagging;
Explanation of buyer verification processes and international buyer profiles.
Many first-time visitors from China remarked that although they had heard of Drugdu.com before, this face-to-face interaction gave them a much clearer understanding of the platform and significantly increased their confidence in future cooperation.
03|Industry Focus: The Long-Term Value of B2B Platforms Beyond Exhibitions
At the event, Drugdu.com also attracted attention from industry media and overseas buyers, who raised several key questions:
How does the platform vet buyers in international pharmaceutical trade?
How does the platform help assess regulatory requirements in different countries?
Does the platform provide sustainable traffic and buyer outreach beyond the exhibition period?
The Drugdu marketing team responded:
“We believe exhibitions are just the starting point—our platform is the core. Drugdu is not a one-time connection tool, but a digital infrastructure that supports continuous lead generation and long-term international growth for our clients.”
04|Looking Ahead: Stronger Connections, Broader Integration
In the second half of 2025, Drugdu.com will further expand its presence at global exhibitions and strengthen the integration between the platform and these events. Key development areas include:
Enhancing the display quality and clarity of product information;
Improving international buyer profiling and behavioral analytics;
Launching multilingual product display guidelines and user tutorials.
05|Outlook
CPhI China 2025 provided Drugdu.com not only with an opportunity to shine on the international stage but also a high-impact platform for direct dialogue with buyers and suppliers. Moving forward, Drugdu will continue to uphold the philosophy of “digital tools as the bridge, real connections as the foundation,” helping Chinese pharmaceutical companies build precise, efficient, and sustainable global partnerships.
Stay connected with Drugdu.com for more platform updates and services:
Website: drugdu.com
Email: service@drugdu.com
WeChat: drugdu2
WhatsApp: +86-18124684783
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.